Shire plc's Vyvanse can now be treated not only among children but also adults.
Approved in July 2007 to treat attention deficit hyperactivity disorder (ADHD) in kids six to 12 years of age, Shire plc's
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.